[(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate

C29H37N5O9S — CID 89015974

IUPAC[(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate
SMILESO=CO[C@@H]1C[C@H]2C(=O)N[C@]3(C(=O)NS(=O)(=O)C4CC4)C[C@H]3/C=C\CCCCC[C@H](Nc3c(N4CCC4)c(=O)c3=O)C(=O)N2C1
InChIInChI=1S/C29H37N5O9S/c35-16-43-18-13-21-26(38)31-29(28(40)32-44(41,42)19-9-10-19)14-17(29)7-4-2-1-3-5-8-20(27(39)34(21)15-18)30-22-23(25(37)24(22)36)33-11-6-12-33/h4,7,16-21,30H,1-3,5-6,8-15H2,(H,31,38)(H,32,40)/b7-4-/t17-,18-,20+,21+,29-/m1/s1
InChIKeyOUDDKQSKSWNTAN-XPPALRGSSA-N
MW631.71 g/mol
LogP-0.58
Rot. Bonds8

About [(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate

[(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate (PubChem CID 89015974) has the molecular formula C29H37N5O9S and a molecular weight of 631.71 g/mol. Its IUPAC name is [(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate.

Molecular Properties

Compound Name[(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate
PubChem CID89015974
Molecular FormulaC29H37N5O9S
Molecular Weight631.71 g/mol
Exact Mass631.23
IUPAC Name[(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate
SMILESO=CO[C@@H]1C[C@H]2C(=O)N[C@]3(C(=O)NS(=O)(=O)C4CC4)C[C@H]3/C=C\CCCCC[C@H](Nc3c(N4CCC4)c(=O)c3=O)C(=O)N2C1
InChIInChI=1S/C29H37N5O9S/c35-16-43-18-13-21-26(38)31-29(28(40)32-44(41,42)19-9-10-19)14-17(29)7-4-2-1-3-5-8-20(27(39)34(21)15-18)30-22-23(25(37)24(22)36)33-11-6-12-33/h4,7,16-21,30H,1-3,5-6,8-15H2,(H,31,38)(H,32,40)/b7-4-/t17-,18-,20+,21+,29-/m1/s1
InChIKeyOUDDKQSKSWNTAN-XPPALRGSSA-N
XLogP-0.58
TPSA188.36 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds8
Heavy Atoms44
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500631.71
LogP ≤ 5-0.58
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate?
The IUPAC name of [(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate (CID 89015974) is [(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate.
What is the SMILES notation for [(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate?
The canonical SMILES for [(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate is O=CO[C@@H]1C[C@H]2C(=O)N[C@]3(C(=O)NS(=O)(=O)C4CC4)C[C@H]3/C=C\CCCCC[C@H](Nc3c(N4CCC4)c(=O)c3=O)C(=O)N2C1.
What is the InChIKey of [(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate?
The InChIKey is OUDDKQSKSWNTAN-XPPALRGSSA-N. The full InChI is InChI=1S/C29H37N5O9S/c35-16-43-18-13-21-26(38)31-29(28(40)32-44(41,42)19-9-10-19)14-17(29)7-4-2-1-3-5-8-20(27(39)34(21)15-18)30-22-23(25(37)24(22)36)33-11-6-12-33/h4,7,16-21,30H,1-3,5-6,8-15H2,(H,31,38)(H,32,40)/b7-4-/t17-,18-,20+,21+,29-/m1/s1.
What are the key properties of [(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate?
[(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate has a molecular weight of 631.71 g/mol, XLogP of -0.58, 8 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,4R,6S,7Z,14S,18R)-14-[[2-(azetidin-1-yl)-3,4-dioxocyclobuten-1-yl]amino]-4-(cyclopropylsulfonylcarbamoyl)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] formate is sourced from PubChem (CID 89015974), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).